All Type of News
Untaken medicine up 23 percent in first half
The total amount of leftover medicine collected for disposal from households across the country rose 23 percent to 168 tons in the first half of this year from 137 tons the previous year.
The Korean Pharmaceutical ...
Government Oks sales of locally-produced Japanese encephalitis vaccine
Korea’s health authorities gave the green light to a local pharmaceutical company on Aug. 9 to sell the nation’s first vaccine for Japanese encephalitis.
Boyung Pharm developed an inactivated Vero cell-derived vacc...
Contest for generic drug in Korean kicks off
The open competition for changing “generic drug” in Korean into other proper language will be closed until Sep. 5 from Aug. 13, according to the Korea Pharmaceutical Manufacturers Association (KPMA).
The associatio...
Covert kickbacks for doctors
The government is stepping up its crackdown on the long-standing practice of offering and receiving kickbacks in the medical community. Yet it remains to be seen whether the illegal practice will be uprooted this time...
CrystalGenomics buys Hwail for 46.8 billion won
Korea’s emerging biotech company CrystalGenomics Inc. said Tuesday it reached a deal to buy Hwail Pharm, a pharmaceutical raw material manufacturer, for 46.8 billion won.
The stock purchase agreement calls for the ...
Green Cross wins $12.5 million flu vaccine contract
Green Cross Corp. has won a contract to supply $12.5 million worth of seasonal influenza vaccines to the Pan American Health Organization (PAHO), the Korean pharmaceutical firm said Tuesday.
A company spokesman sai...
Ilyang recognized as foreign quasi-drug manufacturer in Japan
Ilyang Pharm said Tuesday its Yongin plant has been recognized as an eligible foreign manufacturing facility of quasi-drugs from the Japanese Health, Labor and Welfare.
Under the Japanese health ministry’s recognit...
16 drugmakers rebound in first half
The nation’s sixteen leading drug manufacturers may have bottomed out in earnings in the first half of this year as their sales and operating profits have shown signs of improvement on the back of robust sales of flag...
Ilyang to mass-produce indigenous influenza A vaccine
Ilyang Pharm will market the country's second locally developed vaccine for type A influenza from this Autumn.
Approval was given last Thursday by the the Ministry of Food and Drug Safety (MFDS) for the sales of th...
Whanin forms partnership with Abbott Korea
Whanin Pharm announced on last Thursday that it has entered into a partnership agreement with Abbott Korea for the marketing and distribution of the latter’s Depakote (divalproex sodium) from next month in Korea.
W...
